Cadrenal Therapeutics, Inc. Common Stock (NASDAQ: CVKD) last traded at $0.910, down 2.10% on the session. The quote above updates while this page is open; the figures below are drawn from Cadrenal Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Cadrenal Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker CVKD. Its market capitalisation is $3.25 million.
Valuation measures for Cadrenal Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $3.25M |
|---|---|
| Enterprise value | $2.36M |
| Price / book | 0.79 |
| Beta | 1.97 |
Trailing-twelve-month figures tagged in Cadrenal Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$11.54M |
| Return on equity | -282.13% |
|---|
| Cash | $2.39M |
|---|
Range and volume for CVKD over the past 52 weeks.
| 52-week high | $14.50 |
|---|---|
| 52-week low | $0.850 |
| Volume | 83.8K |
| Average volume | 453.0K |
| Previous close | $0.930 |
Dividend history for Cadrenal Therapeutics, Inc. Common Stock over the trailing twelve months.
| Dividend yield | 1812.99% |
|---|---|
| Dividend per share (TTM) | $16.50 |
Invest a chosen dollar amount in Cadrenal Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell CVKD.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.